As of Jul 14, 2025, Channel Therapeutics Corporation has 6,457 shares failed to deliver, representing 10.40% of the average daily volume of 62,105 shares. Over the past year, the monthly average FTD is 3,005 shares, with the current level 115% above the historical average, indicating elevated settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.